An observational study in Infertility, sponsored by Progyny, Inc.. Status unknown at 12 sites in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2015-03-26.
Sponsored by Progyny, Inc. · Observational
The purpose of this study is to record and evaluate the use of traditional morphology grading combined with Eeva in the treatment of in vitro fertilization.
This is a prospective, observational, single-arm, nonrandomized, multicenter study. Data will be collected to establish eligibility, at baseline, during the stimulation and in vitro fertilization process, during embryo culture, at embryo transfer, at 12-18 days post egg retrieval to verify biochemical pregnancy, and then typically at 5-6 weeks gestational weeks to verify clinical pregnancy.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's planned enrollment of 1,200 is above the median of 200 across 714 observational studies indexed under Infertility.
Browse Infertility studies →Progyny, Inc. is the lead sponsor of 10 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients undergoing in vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.
Exclusion Criteria:
Patients undergoing in-vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.
Device: In-vitro fertilization using Eeva
Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.
Clinical Pregnancy Rate
Determined by first pregnancy ultrasound outcome and optional 12-month phone follow-up
Time frame: 5-6 gestational weeks
Multiple Pregnancy Rate
Determined by follow-up pregnancy ultrasound outcome
Time frame: 5-6 gestational weeks
Spontaneous Miscarriage Rate
Determined by follow-up pregnancy ultrasound outcome
Time frame: 5-6 gestational weeks
This study is status unknown, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Progyny, Inc.